Medicare Enrolled
Dr. Jose Melo, M.D.
Hematology & Oncology · Plantation, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Melo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melo
Dr. Jose Melo is a hematology & oncology specialist in Plantation, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Melo performed 104,859 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Melo received a total of $34,078 from 84 pharmaceutical and/or device companies across 1910 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in FL
$34,078 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗104,859
Medicare services
Top 7% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
47,500 | $2 | $21 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
42,000 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 7,200 | $18 | $71 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,425 | $8 | $35 |
| Iron infusion (Monoferric) | 1,400 | $17 | $72 |
| Anti-nausea injection (ondansetron/Zofran) | 1,272 | $0 | $4 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,130 | $6 | $30 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
808 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
659 | $68 | $148 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
358 | $11 | $93 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
168 | $66 | $158 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
156 | $23 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
153 | $49 | $304 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
146 | $105 | $686 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
110 | $145 | $412 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $44 | $120 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
88 | $1 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
73 | $12 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $133 | $343 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $90 | $224 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $100 | $241 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
41.8% high complexity
55.7% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,078
Total received (2018-2024)
Avg $4,868/year across 7 years
Top 18% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,910
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,589
2023
$5,605
2022
$5,168
2021
$5,400
2020
$3,903
2019
$4,414
2018
$4,000
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$578
PFIZER INC.
$574
Merck Sharp & Dohme LLC
$378
Takeda Pharmaceuticals U.S.A., Inc.
$301
Exelixis Inc.
$292
E.R. Squibb & Sons, L.L.C.
$263
Celgene Corporation
$241
Novartis Pharmaceuticals Corporation
$240
Lilly USA, LLC
$222
Janssen Biotech, Inc.
$208
Eisai Inc.
$204
GENZYME CORPORATION
$188
Daiichi Sankyo Inc.
$186
Incyte Corporation
$177
Genentech USA, Inc.
$156
Pharmacosmos Therapeutics Inc.
$102
SEAGEN INC.
$100
SANOFI-AVENTIS U.S. LLC
$100
ARRAY BIOPHARMA INC
$90
Rigel Pharmaceuticals, Inc.
$87
TAIHO ONCOLOGY, INC.
$79
ABBVIE INC.
$74
Alexion Pharmaceuticals, Inc.
$65
BeiGene USA, Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
PUMA BIOTECHNOLOGY, INC.
$54
SHIELD THERAPEUTICS INC
$54
SERVIER PHARMACEUTICALS LLC
$54
Sumitomo Pharma America, Inc.
$45
RECORDATI_RARE_DISEASES_INC.
$41
Gilead Sciences, Inc.
$40
Mirati Therapeutics, Inc.
$39
JAZZ PHARMACEUTICALS INC.
$37
Ipsen Biopharmaceuticals, Inc
$30
Amneal Pharmaceuticals LLC
$28
Adaptive Biotechnologies Corporation
$26
Deciphera Pharmaceuticals Inc.
$26
Kyowa Kirin, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Regeneron Healthcare Solutions, Inc.
$23
Tolmar, Inc.
$19
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,148
Novartis Pharmaceuticals Corporation
$3,117
Janssen Biotech, Inc.
$2,255
Genentech USA, Inc.
$2,102
PFIZER INC.
$2,080
E.R. Squibb & Sons, L.L.C.
$1,604
Astellas Pharma US Inc
$1,385
Incyte Corporation
$1,303
Celgene Corporation
$1,129
Seagen Inc.
$1,106
Amgen Inc.
$1,011
Merck Sharp & Dohme LLC
$921
Exelixis Inc.
$845
Lilly USA, LLC
$823
Takeda Pharmaceuticals U.S.A., Inc.
$798
GENZYME CORPORATION
$718
Eisai Inc.
$713
Merck Sharp & Dohme Corporation
$558
Rigel Pharmaceuticals, Inc.
$458
Seattle Genetics, Inc.
$366
ABBVIE INC.
$355
Daiichi Sankyo Inc.
$351
ARRAY BIOPHARMA INC
$280
GlaxoSmithKline, LLC.
$276
EISAI INC.
$272
Deciphera Pharmaceuticals Inc.
$250
Ipsen Biopharmaceuticals, Inc
$245
Foundation Medicine, Inc.
$243
Bayer HealthCare Pharmaceuticals Inc.
$234
Pharmacosmos Therapeutics Inc.
$219
Alexion Pharmaceuticals, Inc.
$212
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
AVEO Pharmaceuticals, Inc.
$203
PUMA BIOTECHNOLOGY, INC.
$199
Mirati Therapeutics, Inc.
$199
JAZZ PHARMACEUTICALS INC.
$196
Regeneron Healthcare Solutions, Inc.
$193
BeiGene USA, Inc.
$190
Pharmacyclics LLC, An AbbVie Company
$190
Puma Biotechnology, Inc.
$180
Karyopharm Therapeutics Inc.
$180
AbbVie, Inc.
$173
NOVARTIS PHARMACEUTICALS CORPORATION
$167
AbbVie Inc.
$146
Dova Pharmaceuticals
$144
TAIHO ONCOLOGY, INC.
$141
Adaptive Biotechnologies Corporation
$141
EMD Serono, Inc.
$135
Janssen Pharmaceuticals, Inc
$105
Bayer Healthcare Pharmaceuticals Inc.
$105
SEAGEN INC.
$100
SANOFI-AVENTIS U.S. LLC
$100
Agios Pharmaceuticals, Inc.
$72
Sirtex Medical Inc
$65
Kyowa Kirin, Inc.
$61
Teva Pharmaceuticals USA, Inc.
$60
Myovant Sciences Inc.
$59
MEDIVATION FIELD SOLUTIONS LLC
$59
Amneal Pharmaceuticals LLC
$54
SHIELD THERAPEUTICS INC
$54
Blueprint Medicines Corporation
$54
SERVIER PHARMACEUTICALS LLC
$54
Taiho Oncology, Inc.
$53
Jazz Pharmaceuticals Inc.
$52
Gilead Sciences, Inc.
$52
TG Therapeutics, Inc.
$48
Sobi, Inc
$47
Acceleron Pharma, Inc.
$45
Sumitomo Pharma America, Inc.
$45
MorphoSys, US Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$41
Epizyme, Inc.,
$37
Alnylam Pharmaceuticals Inc.
$27
Sun Pharmaceutical Industries Inc.
$25
Sandoz Inc.
$24
Secura Bio, Inc.
$24
Servier Pharmaceuticals LLC
$22
ADC Therapeutics America, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$20
TG THERAPEUTICS, INC.
$20
Tolmar, Inc.
$19
G1 Therapeutics, Inc.
$18
Advanced Accelerator Applications
$18
SOBI, INC
$15
Top 3 companies account for 25.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY · ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BENDEKA · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · INVOKANA · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Non-Covered Product · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rozlytrek · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VYNDAQEL · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZARXIO · ZEJULA · ZEPZELCA · ZIEXTENZO · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
116
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
WESTSIDE REGIONAL MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Melo is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Melo experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Melo performed 47,500 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Melo receive payments from pharmaceutical companies?
Yes. Dr. Melo received a total of $34,078 from 84 companies across 1,910 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melo's costs compare to other hematology & oncology specialists in Plantation?
Dr. Melo's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Plantation
Browse hematology & oncology specialists in Plantation ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology